热门出版物 - 学术资源搜索

h5 指数:52
h5 中位数:68

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#14 Urology & Nephrology

标题/作者	引用次数	年份
A Systematic Review on the Role of Imaging in Early Recurrent Prostate Cancer PJL De Visschere, C Standaert, JJ Fütterer, GM Villeirs, V Panebianco, ... European Urology Oncology 2 (1), 47-76	149	2019
Epidemiology and Prevention of Prostate Cancer G Gandaglia, R Leni, F Bray, N Fleshner, SJ Freedland, A Kibel, P Stattin, ... European Urology Oncology 4 (6), 877-892	133	2021
Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for 177Lu-labelled PSMA Radioligand Therapy SP Thang, J Violet, S Sandhu, A Iravani, T Akhurst, G Kong, AR Kumar, ... European Urology Oncology 2 (6), 670-676	129	2019
Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trial F Giganti, C Allen, M Emberton, CM Moore, V Kasivisvanathan, ... European Urology Oncology 3 (5), 615-619	128	2020
Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis S Woo, V Panebianco, Y Narumi, F Del Giudice, VF Muglia, M Takeuchi, ... European Urology Oncology 3 (3), 306-315	107	2020
Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non–muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial JA Witjes, J Morote, EB Cornel, G Gakis, FJP van Valenberg, F Lozano, ... European Urology Oncology 1 (4), 307-313	103	2018
Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Detected via Prostate-specific Membrane Antigen Positron Emission Tomography A Kneebone, G Hruby, H Ainsworth, K Byrne, C Brown, L Guo, A Guminski, ... European Urology Oncology 1 (6), 531-537	102	2018
Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States HD Patel, M Gupta, GA Joice, A Srivastava, R Alam, ME Allaf, ... European Urology Oncology 2 (4), 343-348	99	2019
What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines Panel Systematic Review E Veskimäe, EL Espinos, HM Bruins, Y Yuan, R Sylvester, AM Kamat, ... European Urology Oncology 2 (6), 625-642	92	2019
Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies NG Zaorsky, EJ Lehrer, G Kothari, AV Louie, S Siva European Urology Oncology 2 (5), 515-523	90	2019
COVID-19 and Bacillus Calmette-Guérin: What is the Link? PK Hegarty, JP Sfakianos, G Giannarini, AR DiNardo, AM Kamat European Urology Oncology 3 (3), 259-261	89	2020
Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review I Ouzaid, U Capitanio, M Staehler, CG Wood, BC Leibovich, B Ljungberg, ... European Urology Oncology 2 (2), 141-149	84	2019
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis E Mazzone, A Stabile, F Pellegrino, G Basile, D Cignoli, GO Cirulli, ... European Urology Oncology 4 (5), 697-713	82	2021
Role of Active Surveillance for Localized Small Renal Masses MC Mir, U Capitanio, R Bertolo, I Ouzaid, M Salagierski, M Kriegmair, ... European Urology Oncology 1 (3), 177-187	80	2018
Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer R Aggarwal, X Wei, W Kim, EJ Small, CJ Ryan, P Carroll, M Cooperberg, ... European Urology Oncology 1 (1), 78-82	79	2018
First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis F Quhal, K Mori, A Bruchbacher, I Resch, H Mostafaei, B Pradere, ... European Urology Oncology 4 (5), 755-765	79	2021
Comparison of the Diagnostic Accuracy of Micro-ultrasound and Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies for the Diagnosis of Clinically Significant Prostate Cancer G Lughezzani, A Saita, M Lazzeri, M Paciotti, D Maffei, G Lista, R Hurle, ... European Urology Oncology 2 (3), 329-332	77	2019
Prebiopsy Biparametric Magnetic Resonance Imaging Combined with Prostate-specific Antigen Density in Detecting and Ruling out Gleason 7–10 Prostate Cancer in Biopsy-naïve Men L Boesen, N Nørgaard, V Løgager, I Balslev, R Bisbjerg, KC Thestrup, ... European Urology Oncology 2 (3), 311-319	76	2019
Impact of Centralizing Care for Genitourinary Malignancies to High-volume Providers: A Systematic Review SB Williams, MD Ray-Zack, HK Hudgins, J Oldenburg, QD Trinh, ... European Urology Oncology 2 (3), 265-273	76	2019
Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel S Fernández-Pello, M Hora, T Kuusk, R Tahbaz, S Dabestani, ... European Urology Oncology 3 (1), 57-72	75	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。